MUCUS RELIEF- guaifenesin 400 mg tablet 
Health Pharma USA LLC

----------

Guaifenesin 400 mg Caplets

Active ingredient (in each tablet)

Guaifenesin 400 mg

Purpose

Expectorant

Uses

Warnings

ask a doctor before use if you have

When using this product

  • do not exceed recommended dosage
  • do not use for more than 7 days

Stop use and ask a doctor if

  • cough lasts for more than 7 days, recurs, or is accompanied by fever, rash, or persistent headache.

These could be signs of a serious condition.

If pregnant or breast-feeding,ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

maltodextrin, povidone, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, silicon dioxide, stearic acid

Questions or comments?

Call 1-844-832-1138

Monday-Friday 9AM – 5PM

Principal Display Panel

Guaifenesin 400 mg

Expectorant

label

MUCUS RELIEF 
guaifenesin 400 mg tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71679-119
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN400 mg
Inactive Ingredients
Ingredient NameStrength
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
POVIDONE (UNII: FZ989GH94E)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Product Characteristics
ColorwhiteScoreno score
ShapeOVALSize17mm
FlavorImprint Code G400
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:71679-119-6060 in 1 BOTTLE; Type 0: Not a Combination Product12/20/2021
2NDC:71679-119-02200 in 1 BOTTLE; Type 0: Not a Combination Product12/20/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01204/13/2016
Labeler - Health Pharma USA LLC (080804485)
Establishment
NameAddressID/FEIBusiness Operations
Health Pharma USA LLC080804485manufacture(71679-119)

Revised: 10/2023
Document Id: 08da137b-bf4d-886c-e063-6294a90a1da3
Set id: d60a3e9d-e88e-3b19-e053-2995a90a3e8d
Version: 3
Effective Time: 20231020
 
Health Pharma USA LLC